C Celltrion 068270 · KRX · Healthcare
OpenDART ↗ OpenDART Filings checked 23 Oct 2026, 17:20 UTC Financials checked 23 Oct 2026, 17:20 UTC
Some records were last checked more than 24 hours ago. These are the last verified records; check the official source for the latest filings.
Annual reporting period: 2025-01-01 — 2025-12-31 · KRW
Annual revenue ₩4.16T Year over year +17.0%
Annual net income ₩1.03T Consolidated net income
Annual operating income ₩1.17T Consolidated basis
Operating margin 28.1% Operating income / revenue
Revenue over time ANNUAL
2021-12-31 · 1,911,601,263,030 KRW
2021 ₩1.91T
2022-12-31 · 2,283,967,480,394 KRW
2022 ₩2.28T
2023-12-31 · 2,176,431,531,380 KRW
2023 ₩2.18T
2024-12-31 · 3,557,303,554,371 KRW
2024 ₩3.56T
2025-12-31 · 4,162,495,108,881 KRW
2025 ₩4.16T Each bar is one fiscal year of revenue, ending on the date shown.
Income statement CONSOLIDATED Line 2025 2024 2023 2022 2021 Revenue ₩4.16T ₩3.56T ₩2.18T ₩2.28T ₩1.91T Cost of revenue ₩1.7T ₩1.88T ₩1.12T ₩1.25T ₩805.81B Gross profit ₩2.47T ₩1.68T ₩1.05T ₩1.03T ₩1.11T Selling, general and administrative ₩1.3T ₩1.19T ₩400.39B ₩385.5B ₩348.94B Operating income ₩1.17T ₩492.02B ₩651.48B ₩647.2B ₩756.86B Non-operating income ₩328.65B ₩240.25B ₩54.19B ₩47.52B ₩53.51B Income tax expense ₩122.24B ₩157.23B ₩131.39B ₩94.83B ₩155.53B Net income ₩1.03T ₩418.88B ₩539.71B ₩542.57B ₩595.78B Basic EPS 4,668.00 2,048.00 3,759.00 3,894.00 4,244.00 Diluted EPS 4,660.00 2,045.00 3,753.00 3,888.00 4,224.00
Balance sheet CONSOLIDATED Line 2025 2024 2023 2022 2021 Total assets ₩22.33T ₩21.06T ₩19.92T ₩5.89T ₩5.67T Current assets ₩6.21T ₩5.58T ₩5.01T ₩2.93T ₩3.07T Cash and equivalents ₩1.12T ₩996.43B ₩564.61B ₩551.19B ₩1.19T Accounts receivable ₩1.79T ₩1.22T ₩939.17B ₩1.62T ₩1.1T Inventory ₩2.8T ₩2.77T ₩3.04T ₩616.35B ₩578.06B Property, plant and equipment ₩1.7T ₩1.24T ₩1.21T ₩1.01T ₩950.41B Total liabilities ₩4.98T ₩3.48T ₩2.79T ₩1.62T ₩1.62T Current liabilities ₩4.45T ₩3.19T ₩2.47T ₩1.29T ₩1.21T Accounts payable ₩124.59B ₩75.31B ₩50.85B ₩50.27B ₩80.72B Shareholders' equity ₩17.35T ₩17.58T ₩17.13T ₩4.27T ₩4.05T Retained earnings ₩4.41T ₩3.74T ₩3.96T ₩3.49T ₩3.05T
Cash flow statement CONSOLIDATED Line 2025 2024 2023 2022 2021 Operating cash flow ₩646.05B ₩901.87B ₩537.16B ₩863.53M ₩911.16B Investing cash flow ₩-860.42B ₩-169.39B ₩-138.86B ₩-297.05B ₩-355.83B Financing cash flow ₩339.32B ₩-353.04B ₩-385.11B ₩-350.22B ₩-69.28B Capital expenditure ₩108.22B ₩135.06B ₩210.05B ₩-111.17B ₩-63.38B Share buybacks ₩907.29B ₩436.32B — ₩-280.55B ₩-39.13B
Key ratios COMPUTED HERE Line 2025 2024 2023 2022 2021 Gross margin 59.3% 47.3% 48.3% 45.2% 57.8% Operating margin 28.1% 13.8% 29.9% 28.3% 39.6% Net margin 24.8% 11.8% 24.8% 23.8% 31.2% Return on equity 5.9% 2.4% 3.2% 12.7% 14.7% Return on assets 4.6% 2.0% 2.7% 9.2% 10.5% Asset turnover 0.19× 0.17× 0.11× 0.39× 0.34× Current ratio 1.39× 1.75× 2.03× 2.26× 2.54× Debt to equity 28.7% 19.8% 16.3% 37.8% 40.1% Net debt ₩-1.12T ₩-996.43B ₩-564.61B ₩-551.19B ₩-1.19T Free cash flow ₩537.83B ₩766.81B ₩327.11B ₩-110.31B ₩847.78B Cash conversion cycle 734d 648d 1,128d 424d 436d
Amounts are as filed. An em dash means that line was not reported, not that it is nil; rows marked “computed” and the whole key-ratios table are worked out here from those amounts.
About this record 5 fiscal years from 2021 to 2025, covering 26 statement lines, collected from OpenDART. The most recent was confirmed on 2025-12-31.
Its 28.07% operating margin in the latest fiscal year is at or above 69% of the 45 listed companies collected here, closest to Coca-Cola 28.71% and Netflix 29.49%.
This page offers no investment view or forecast about Celltrion. The amounts are as the company filed them, the ratios follow from those amounts, and no currency is converted.
Run these figures through the calculators · Reading guides · Methodology